<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Trieste_data"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:Trieste/data">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Trieste/data&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Trieste/data&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Trieste/data&amp;action=history">History               </A></LI><LI style="color:#808080;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Trieste/data" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform">Â </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Trieste/data</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2012.igem.org</H3><DIV id="head"><TITLE>Team Trieste iGEM 2012</TITLE></DIV><DIV id="body"><DIV id="container"><DIV id="header"><DIV id="payoff">The Jolly JoCare<DIV>a safe probiotic platform for protein expression</DIV></DIV><UL id="navigation"><LI><A href="https://2012.igem.org/Team:Trieste">HOME</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/team">TEAM</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/team">Team</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/City&amp;Lab">City&amp;Lab</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/Team Gal">Team Gallery</A></LI></UL><LI><A href="https://2012.igem.org/Team:Trieste/project">PROJECT</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/project">Abstract</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/project/overview">Project Overview</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/project/applications">Applications</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/project/modeling">Modeling</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/project/mainres">Main Results</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/data">DATA</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/parts">PARTS</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/notebook">DIARY</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/notebook">Notebook</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/protocols">Protocols</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/safety">SAFETY</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/safety">Safety</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/survey">Safety Survey</A></LI><LI><A href="http://www.icgeb.org/~bsafesrv/" target="_blank">ICGEB Safety Unit</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/outreach">OUTREACH</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/outreach">Human Practice</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/outreach/press">Press</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/extra">EXTRA</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/extra">Attributions</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/extra/ach">Achievements</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/extra/aks">Acknowledgement</A></LI></DIV><DIV id="content"><H1 id="h1_lf" class="main_tit"><DIV>Data</DIV></H1><H1 id="h1_rt" class="main_tit"><DIV>More</DIV></H1><DIV id="box_main"><DIV class="box_contenuti"><H1>An overview of our system</H1><P><STRONG>This is a diagram summarising our system. It consists of two parts: the production of Ab against NoroVirus and the gene guard.</STRONG>
						Concerning the gene guard, CymR inhibits the T5 Cumate Operator Promoter avoiding the production of the T4 Holin (permeabilizes the cytoplasmatic membrane) and the LL 37 cathelicidin (human antimicrobial peptide able to disrupt the outer membrane).
						When the cumate is given, it binds and inactivates the CymR, derepressing the T5 Cumate Operator Promoter and allowing the expression of T4 Holin, that permeabilizes the cytoplasmatic membrane, allowing the secretion of LL 37 that disrupt the outer membrane.
						Moreover, the horizontal transfer from our Nissle into another bacteria is avoided thanks to our gene guard. The receiving bacteria do not produce the CymR repressor, so the T5 Cumate Operator Promoter is activated allowing T4 Holin and LL 37 expression. Bacteria die!
					</P><H2> Our favourite parts:</H2><TABLE><TBODY><TR><TD><H3><A href="https://2012.igem.org/Team:Trieste/parts/1">BBa_K875001</A>, T5 cumate operator:</H3> 
									We demonstrated that this promoter is very strong and strictly regulated. Thanks to its rapid responsiveness it's one of the first candidates for the toxin expression and production in case of necessity.
								</TD></TR><TR><TD><H3><A href="https://2012.igem.org/Team:Trieste/parts/3">BBa_K875003</A>, CymR:</H3>
									We expressed succesfully the CymR. We also showed his stringency as repressor of the T5 Cumate Operator. Together, CymR and T5 Cumate Operator, create a safe and tightly regulated gene guard system, which keeps under control the bacterial growth.
								</TD></TR><TR><TD><H3><A href="ttp://2012.igem.org/Team:Trieste/parts/4">BBa_K875004</A>, LPP-OmpA-scFv:</H3> 
									We verified the production of this protein at high yield. LPP-OmpA system is a very powerful method for protein display on the outer membrane, in this case the antibody scFv 54.6.
								</TD></TR></TBODY></TABLE><H2>The part we improved:</H2><TABLE><TBODY><TR><TD><H3><A href="https://2012.igem.org/Team:Trieste/parts/10">BBa_K875020</A>, Beta-Glucosidase (Osaka 2010):</H3> 
									This composite part is developed by previous work by UNITS iGEM team 2011 and Edinburgh team 2011. We improved and characterized this part demonstrating its efficiency.
								</TD></TR></TBODY></TABLE><H2>Other parts that we developed:</H2><H3><A href="https://2012.igem.org/Team:Trieste/parts/2">BBa_K875002</A>, T5 Lac Operator:</H3>
						We showed that this promoter comes very handy for protein expression tests.
					<H3><A href="https://2012.igem.org/Team:Trieste/parts/5">BBa_K875005</A>, LPP-OmpA-SIP:</H3>
						We designed this biobrick containing SIP as a valid alternative to scFv, because SIP confers bivalent binding properties to the antibody.
					<H3><A href="https://2012.igem.org/Team:Trieste/parts/6">BBa_K875006</A>, PelB-scFv:</H3>
						We created this composit biobrick to use as a system which allows secretion of proteins, in this case the antibody, first into periplasm and then extracellularly.
					<H3><A href="https://2012.igem.org/Team:Trieste/parts/7">BBa_K875007</A>, PelB-SIP:</H3>
						We built this biobrick (secreted version of SIP) because soluble form of SIP plays an important role in enteric infections.
					<H3><A href="https://2012.igem.org/Team:Trieste/parts/8">BBa_K875008</A>, Tse2 toxin:</H3>
						We demonstrated that this composit is an important suicide mechanism able to arrest the growth of prokaryotic cells.
					<H3><A href="https://2012.igem.org/Team:Trieste/parts/9">BBa_K875009</A>, LL 37:</H3>
						The LL 37 is a very powerful human antimicrobial peptide that kills bacteria. 
						We are developing a new construct combining the toxin with the T4 holin which breaks the inner membrane allowing the  LL 37 to reach his target.
					</DIV></DIV><DIV id="box_right"><UL id="sub_menu"><LI class="select"><A href="https://2012.igem.org/Team:Trieste/data">Data</A></LI></UL><DIV class="box_contacts"><H2>Contact us</H2><P>For other information, write to:</P><A href="mailto:igem2012@gmail.com" class="btn">igem2012@gmail.com</A><DIV class="social">
						Follow us also:
						</DIV></DIV></DIV></DIV><DIV id="footer"><DIV id="box_footer">iGEM 2012 - For info: <A href="mailto:igem2012@gmail.com">igem2012@gmail.com</A></DIV></DIV></DIV></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2012.igem.org/Team:Trieste/data">http://2012.igem.org/Team:Trieste/data</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Trieste/data" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Trieste/data" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Trieste/data&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Trieste/data&amp;oldid=269704" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2012.igem.org:Privacy_policy" title="2012.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2012.igem.org:General_disclaimer" title="2012.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>